Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity in the Colon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06978400
What this trial is testing

Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 64
Post-approval studies (Phase 4)Study completedNCT01641458
What this trial is testing

Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients

Who this might be right for
Colorectal Cancer
Cantonal Hospital of St. Gallen 37
Testing effectiveness (Phase 2)Looking for participantsNCT06888843
What this trial is testing

Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Nizhny Novgorod Regional Clinical Oncology Center 160
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Early research (Phase 1)Study completedNCT06048367
What this trial is testing

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorLung CancerPancreas Cancer+6 more
Sichuan Enray Pharmaceutical Sciences Company 19
Not applicableUnknownNCT05339230
What this trial is testing

Role of Antisecretory Factor in Dihydropyrimidine Treatment of Colorectal Cancer

Who this might be right for
Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer
Uppsala University Hospital 73
Not applicableStudy completedNCT07177560
What this trial is testing

Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

Who this might be right for
Colorectal CancerGastric Cancer (GC)Capecitabine+1 more
Gazi University 151
Not applicableStudy completedNCT04528745
What this trial is testing

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Who this might be right for
Pancreas CancerColorectal Cancer
University of Copenhagen 52
Not applicableStudy completedNCT03421912
What this trial is testing

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Who this might be right for
Head and Neck Squamous Cell CarcinomaColorectal CancerNon Small Cell Lung Cancer+1 more
Centre Leon Berard 102
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Not applicableLooking for participantsNCT05655780
What this trial is testing

The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment

Who this might be right for
Colorectal Neoplasms
Maastricht University Medical Center 104
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Not applicableStudy completedNCT01280513
What this trial is testing

Effect of Increased Protein Intake on Colonic Metabolism

Who this might be right for
Protein FermentationToxicity in the Colon
KU Leuven 20
Not applicableUnknownNCT03852290
What this trial is testing

C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer

Who this might be right for
Colon CancerMTHFR Gene MutationChemotherapeutic Toxicity+1 more
Universidad de Costa Rica 65
Not applicableEnded earlyNCT01547923
What this trial is testing

Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines

Who this might be right for
Colorectal CancerIntravenous 5 Fluorouracile
Institut Cancerologie de l'Ouest 1,142
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Early research (Phase 1)Study completedNCT01859858
What this trial is testing

Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

Who this might be right for
Advanced Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableLooking for participantsNCT07296887
What this trial is testing

CARE Tool Study Aim 3

Who this might be right for
Gynecologic CancerProstate CancerLung Cancer+1 more
Washington University School of Medicine 430
Next Page